TargetMol

AZD-3199 free base

Product Code:
 
TAR-T26714
Product Group:
 
Inhibitors and Activators
Supplier:
 
TargetMol
Regulatory Status:
 
RUO
Shipping:
 
cool pack
Storage:
 
-20℃
1 / 1
❮❯

No additional charges, what you see is what you pay! *

CodeSizePrice
TAR-T26714-5mg5mg£1,412.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T26714-50mg50mg£2,785.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T26714-100mg100mg£3,765.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
Prices exclude any Taxes / VAT
How to order with us   Contact us
Stay in control of your spending. These prices have no additional charges, not even shipping!
* Rare exceptions are clearly labelled (only 0.14% of items!).
Multibuy discounts available! Contact us to find what you can save.
This product comes from: United States.
Typical lead time: 10-14 working days.
Contact us for more accurate information.
  • Further Information
  • Documents
  • References
  • Show All

Further Information

Bioactivity:
AZD-3199, a β2 adrenergic receptor agonist, is used potentially for the treatment of asthma and chronic obstructive.
CAS:
925243-19-2
Formula:
C32H42N4O4S
Molecular Weight:
578.77
Purity:
0.98
SMILES:
CCN(CC)CCN(CCNCCc1ccc(O)c2[nH]c(=O)sc12)C(=O)CCOCCc1cccc2ccccc12

References

1. Bjermer L, Kuna P, Jorup C, Bengtsson T, Rosenborg J. Clinical pharmacokinetics of AZD3199, an inhaled ultra-long-acting ?2-adrenoreceptor agonist (uLABA). Drug Des Devel Ther. 2015 Feb 5;9:753-62. doi: 10.2147/DDDT.S66049. PubMed PMID: 25709399; PubMed Central PMCID: PMC4330041. 2. Bjermer L, Rosenborg J, Bengtsson T, L?tvall J. Comparison of the bronchodilator and systemic effects of AZD3199, an inhaled ultra-long-acting ??-adrenoceptor agonist, with formoterol in patients with asthma. Ther Adv Respir Dis. 2013 Oct;7(5):264-71. doi: 10.1177/1753465813497527. PubMed PMID: 23907810. 3. Kuna P, Ivanov Y, Trofimov VI, Saito T, Beckman O, Bengtsson T, Jorup C, Maltais F. Efficacy and safety of AZD3199 vs formoterol in COPD: a randomized, double-blind study. Respir Res. 2013 Jun 3;14:64. doi: 10.1186/1465-9921-14-64. PubMed PMID: 23731768; PubMed Central PMCID: PMC3691744. 4. Norman P. Which of three structures is AZD-3199? WO-2008104790, WO-2008096112 and WO-2008096119. Expert Opin Ther Pat. 2009 Aug;19(8):1157-63. doi: 10.1517/13543770902815527. PubMed PMID: 19563269.